Fibrocystic breast changes: Clinical sciences

Last updated: January 30, 2025

Fibrocystic breast changes: Clinical sciences

ENR EXAM 1

ENR EXAM 1

Anatomy and physiology of the male reproductive system
Anatomy of the male reproductive organs of the pelvis
Development of the reproductive system
Anatomy of the male urogenital triangle
Testicular cancer
Anatomy clinical correlates: Male pelvis and perineum
Endocrine system anatomy and physiology
Prostate cancer
Hypopituitarism
Prostate gland histology
Pituitary gland histology
Pituitary apoplexy
Pituitary adenoma
Kallmann syndrome
Testosterone
Androgens and antiandrogens
Testis, ductus deferens, and seminal vesicle histology
Testicular torsion
Klinefelter syndrome
Progestins and antiprogestins
5-alpha-reductase deficiency
Benign prostatic hyperplasia
Erectile dysfunction
Androgen insensitivity syndrome
Turner syndrome
Human development days 1-4
Human development days 4-7
Breast cancer
Breast cancer: Pathology review
Inflammatory breast cancer: Clinical sciences
Breast papilloma: Clinical sciences
Benign breast conditions: Pathology review
Breast abscess: Clinical sciences
Anatomy of the breast
Endometrial cancer
Breast cyst: Clinical sciences
Fibrocystic breast changes: Clinical sciences
Human papillomavirus
Cervical cancer
Vaginal and vulvar disorders: Pathology review
Sexually transmitted infections: Clinical
Vulvar cancer: Clinical
Vaginal cancer: Clinical
Fallopian tube and uterus histology
Uterine stimulants and relaxants
Uterine disorders: Pathology review
Uterine atony: Clinical sciences
Uterine fibroid
Anatomy of the female reproductive organs of the pelvis
Anatomy and physiology of the female reproductive system
Ectopic pregnancy
Pregnancy
Breastfeeding
Contraception: Clinical
Ovarian germ cell tumors
Ovarian sex-cord stromal tumors

Decision-Making Tree

Questions

USMLE® Step 2 style questions USMLE

0 of 3 complete

Start
A 45-year-old woman with no significant past medical history presents to the clinic with complaints of bilateral breast tenderness and lumpiness, particularly in the upper outer quadrants, that she has noticed for the past six months. The symptoms seem to peak just before her menstruation. On examination, there are areas of tender nodularity in both breasts. No nipple discharge, skin changes, or axillary lymphadenopathy is noted. Both ultrasound and mammogram demonstrate heterogenous, distorted parenchyma without discrete masses. Which of the following is recommended for managing this patient’s symptoms?

Transcript

Watch video only

Fibrocystic breast changes include a spectrum of benign breast changes characterized by multiple bilateral nodules within the breast tissue. This condition is most commonly found in females between the ages of 30 and 50 years. Although the exact etiology is not fully understood, a hormonal component, such as overproduction of estrogen and underproduction of progesterone is likely, especially since symptoms like breast pain, also known as mastalgia, tend to worsen in a cyclical pattern towards the end of the menstrual cycle.

Alright, now, when a patient presents with a chief concern suggesting fibrocystic breast changes, the first step is to obtain a focused history and perform a physical examination. The patient might report bilateral breast nodularity, pain, swelling, and possible straw-colored nipple discharge. These symptoms may worsen just prior to menstruation each month. On physical examination, you might find multiple nodular areas, a ropey and lumpy texture, and tenderness on palpation. At this point, you should suspect fibrocystic breast changes.

The next step is to order a breast imaging to confirm your diagnosis. Now, if your patient is younger than 35 years, order a breast ultrasound; but, if your patient is 35 years of age or older, you should obtain both a breast ultrasound and a mammogram.

Okay, let’s talk about the results. If there are no findings on imaging that would indicate fibrocystic breast changes, then you should consider an alternative diagnosis. On the other hand, ultrasound findings consistent with fibrocystic breast changes include fibroglandular tissue, clustered microcysts, distorted breast parenchyma, and an absence of discrete masses. As for the mammogram, it might show heterogeneous and dense breast parenchyma, partially circumscribed cysts, as well as crescent-shaped calcifications in multiple lobes. If you see these findings on imaging, then you are dealing with fibrocystic breast changes.

Alright, now that we diagnosed fibrocystic breast changes, let’s move on to management. Keep in mind that fibrocystic breast changes per se don't need to be treated; what’s actually treated are the symptoms of the disorder, such as mastalgia.

Sources

  1. "Practice Bulletin No. 164: Diagnosis and management of benign breast disorders" Obstet Gynecol (2016)
  2. "Select Choices in Benign Breast Disease: An Initiative of the American Society of Breast Surgeons for the American Board of Internal Medicine Choosing Wisely® Campaign" Ann Surg Oncol (2018)
  3. "Diseases of the Breast" The Mont Reid Surgical Handbook, 7th ed (2018)
  4. "Clustered Microcysts at Breast US: Outcomes and Updates for Appropriate Management Recommendations" Radiology (2020)
  5. "Benign breast diseases: classification, diagnosis, and management" Oncologist (2006)
  6. "Benign breast disorders" N Engl J Med (2005)
  7. "Benign breast disease: when to treat, when to reassure, when to refer" Cleve Clin J Med (2002)